EU approves half-unit insulin pen from Sanofi

10/13/2013 | MedGadget.com

European regulators have granted Sanofi CE mark approval for its JuniorSTAR insulin pen, designed for use in type 1 diabetes patients 6 to 18 years of age. The reusable device supports half-unit dosing increments and works with Insuman, Lantus and Apidra, allowing more insulin dosing flexibility for health care providers.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ